Related Experiment Video
Updated: Aug 13, 2025

10:42
A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
9.7K
Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study
Erika J Laukka1,2, Ingrid Ekström1, Maria Larsson3
1Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|January 23, 2023
Summary
Olfactory dysfunction (OD), or impaired sense of smell, is linked to a higher risk of dementia in older adults. Severe smell loss, particularly with genetic factors, significantly increases dementia hazard.
Area of Science:
- Neuroscience
- Gerontology
- Epidemiology
Background:
- Olfactory dysfunction (OD) is increasingly recognized as a potential early marker for neurodegenerative diseases.
- Identifying reliable predictors of dementia risk is crucial for timely intervention in aging populations.
Purpose of the Study:
- To evaluate olfactory dysfunction (OD) markers for estimating dementia risk in older adults.
- To investigate the combined effect of OD and APOE genotype on dementia hazard.
Main Methods:
- A population-based study (SNAC-K, n=2473, mean age 70) assessed OD using the Sniffin sticks odor identification task.
- Objective and subjective OD, and OD combined with APOE status, were analyzed.
- Dementia hazard over 12 years was estimated using Cox regression.
Main Results:
- OD was associated with a 2.01-fold increased hazard of dementia.
- Severe OD (anosmia) showed the strongest association (2.92-fold increased hazard).
- APOE ε4 carriers with anosmia had the highest dementia hazard (up to 19.84-fold for ε4/ε4).
Conclusions:
- Olfactory dysfunction is a significant predictor of dementia risk in older adults.
- Severe olfactory impairment, especially when combined with genetic predisposition (APOE ε4), substantially elevates dementia risk.
Related Concept Videos
Olfaction
44.8K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
44.8K
Olfactory Receptors: Location and Structure
9.4K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.4K
Dementia
153
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
153
Alzheimer's Disease: Overview
596
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
596

